-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Acadia Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $32.8M.
- Acadia Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $129M.
- Acadia Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$61.3M, a 71.6% increase from 2022.
- Acadia Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$216M, a 28.7% decline from 2021.
- Acadia Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$168M, a 40.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)